S2E10 - Jennifer L. Adams, PharmD, EdD | Post-Scrip: The ASPL Pharmacy Law Podcast
Description
In this episode of Post-Scrip, Henry introduces Jennifer L. Adams, PharmD, EdD. Henry and Jennifer discuss the upcoming Empowering Pharmacists: The Continuum of Prescriptive Authority.
Pharmacist prescriptive authority is a topic that has gained significant attention in recent years, as many healthcare professionals recognize the important role that pharmacists can play in improving patient care. With prescriptive authority, pharmacists can prescribe medications and adjust existing prescriptions, which can result in more timely and effective treatment for patients and increased access to healthcare services. Pharmacists in the U.S. practice in a broad array of regulatory environments, as the practice of pharmacy and pharmacist prescriptive authority is regulated by state legislatures and state agencies.
As states consider regulation of pharmacist prescriptive authority and increasing pharmacists’ scope of practice, the overarching regulatory model used in the state can facilitate or hinder regulation of pharmacist prescriptive authority. Regulating pharmacy practice with a standard of care regulatory model allows for a more streamlined regulation of advanced clinical services such as pharmacist prescribing.
Attendees will leave with skills to articulate how pharmacist prescribing in a standard of care regulatory model allows pharmacists to improve public health through access to healthcare services.
Join us at the 34th annual conference: Developments in Pharmacy Law Seminar , November 2-5, 2023 in San Antonio, Texas
In this episode of Post-Scrip, Henry introduces Jenni Wai, RPh. , MBA, Josh Bolin and Christopher R. Smith, JD, LLM. They discuss the upcoming "Regulatory, Industry and Legal Perspectives on the Future of the DSCSA".This presentation will provide an update on the final stages of implementation of...
Published 10/16/24
In this episode of Post-Scrip, Henry introduces Marty Allain, JD. They discuss the upcoming "How Drug Manufacturer Restrictions and Recent Court Decisions are Re-Shaping 340B Drug Distribution and Delivery Models".Pharmaceutical manufacturers continue to restrict the delivery of 340B drug...
Published 10/09/24